0
CollPlant Biotechnologies Ltd. Banner Image

CollPlant Biotechnologies Ltd.

  • Ticker CLGN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CollPlant Biotechnologies Ltd. Logo Image
  • 11-50 Employees
  • Based in Rehovot, Israel
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. Their products are based on their rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology. Their products address indications for the diverse fields of tissue repair, aesthetics and organMore manufacturing, and, they believe, are ushering in a new era in regenerative and aesthetic medicine. Their flagship rhCollagen BioInk product line is ideal for 3D bioprinting of tissues and organs. In October 2018, they entered into a licensing agreement with United Therapeutics, whereby United Therapeutics is using CollPlant's BioInks in the manufacture of 3D bioprinted lungs for transplant in humans.
CollPlant Biotechnologies Ltd.

Most Recent Responsibility Report

CollPlant Biotechnologies Ltd.
MOST RECENT 2024 ESG Report

CollPlant Biotechnologies Ltd. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived CollPlant Biotechnologies Ltd. Sustainability Report, CollPlant Biotechnologies Ltd. Corporate Social Responsibility Report, CollPlant Biotechnologies Ltd. CSR Report, CollPlant Biotechnologies Ltd. Corporate Responsibility, CollPlant Biotechnologies Ltd. CR Report, CollPlant Biotechnologies Ltd. Citizenship Report, CollPlant Biotechnologies Ltd. ESG Report, and CollPlant Biotechnologies Ltd. Environmental Report online.
CollPlant Biotechnologies Ltd. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!